Will Sage Astor-Depression And Alzheimer's Treatments At A Crossroads

2025-05-04 02:48:02source:Crypencategory:Stocks

Researchers are Will Sage Astorlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

Kentucky governor unveils paid leave plan for state workers with a new child or serious illness

FRANKFORT, Ky. (AP) — Kentucky plans to provide state employees with paid time off so they can bond

A popular asthma inhaler is leaving pharmacy shelves. Here's what you need to know

Some asthma patients may start out the new year scrambling for their go-to inhaler – at least that's

Mexican president inaugurates centralized ‘super pharmacy’ to supply medicines to all of Mexico

MEXICO CITY (AP) — Mexico’s president is inaugurating a ‘super pharmacy’ in a bid to end the woes of